Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.

Taylor AM, Roberts KW, Pradhan AA, Akbari HA, Walwyn W, Lutfy K, Carroll FI, Cahill CM, Evans CJ.

Br J Pharmacol. 2015 Jan;172(2):691-703. doi: 10.1111/bph.12810. Epub 2014 Sep 5.

2.

Involvement of the kappa-opioid receptor in nitrous oxide-induced analgesia in mice.

Koyama T, Fukuda K.

J Anesth. 2010 Apr;24(2):297-9. doi: 10.1007/s00540-010-0886-5. Epub 2010 Feb 17.

PMID:
20157832
3.

Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.

Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS.

J Pharmacol Exp Ther. 2003 Dec;307(3):1054-64. Epub 2003 Oct 13.

PMID:
14557380
4.

Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.

Ong EW, Xue L, Olmstead MC, Cahill CM.

Br J Pharmacol. 2015 Jan;172(2):615-29. doi: 10.1111/bph.12761. Epub 2014 Jul 1.

6.

Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.

Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M.

Brain Res. 2006 Apr 14;1083(1):61-9. Epub 2006 Mar 10.

PMID:
16530171
7.

Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.

Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, Denavit-Saubié M, Severini C, Negri L, Roques BP, Maldonado R, Kieffer BL.

J Neurosci. 1998 Sep 15;18(18):7285-95.

8.

Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.

Xu H, Wang X, Partilla JS, Bishop-Mathis K, Benaderet TS, Dersch CM, Simpson DS, Prisinzano TE, Rothman RB.

Brain Res Bull. 2008 Sep 5;77(1):49-54. doi: 10.1016/j.brainresbull.2008.05.003. Epub 2008 Jun 4.

9.

Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.

Wang YJ, Tao YM, Li FY, Wang YH, Xu XJ, Chen J, Cao YL, Chi ZQ, Neumeyer JL, Zhang A, Liu JG.

J Pharmacol Exp Ther. 2009 Apr;329(1):306-13. doi: 10.1124/jpet.108.142802. Epub 2009 Jan 9.

10.

Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.

Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM.

J Pharmacol Exp Ther. 2002 Sep;302(3):1146-50.

PMID:
12183674
12.

Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.

Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.

J Pharmacol Exp Ther. 2003 Jul;306(1):394-400. Epub 2003 Apr 29.

PMID:
12721333
13.

Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.

Bhalla S, Zhang Z, Patterson N, Gulati A.

Eur J Pharmacol. 2010 Jun 10;635(1-3):62-71. doi: 10.1016/j.ejphar.2010.03.003. Epub 2010 Mar 19.

PMID:
20303944
14.
15.

Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain.

Sukhtankar DD, Lee H, Rice KC, Ko MC.

Psychopharmacology (Berl). 2014 Apr;231(7):1377-87. doi: 10.1007/s00213-013-3341-0. Epub 2013 Nov 12.

16.

Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesia.

Rutten K, Tzschentke TM, Koch T, Schiene K, Christoph T.

Eur J Pharmacol. 2014 Oct 15;741:264-71. doi: 10.1016/j.ejphar.2014.08.011. Epub 2014 Aug 26.

PMID:
25169429
17.

dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.

Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF.

Eur J Pharmacol. 2006 Feb 15;531(1-3):103-7. Epub 2006 Jan 30.

PMID:
16445907
18.

Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents.

Morales L, Perez-Garcia C, Alguacil LF.

Br J Pharmacol. 2001 May;133(1):172-8.

19.

Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain.

Rutten K, Schröder W, Christoph T, Koch T, Tzschentke TM.

Eur J Pharmacol. 2018 May 15;827:41-48. doi: 10.1016/j.ejphar.2018.03.008. Epub 2018 Mar 8.

PMID:
29524385
20.

Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.

Mori T, Ito S, Kita T, Narita M, Suzuki T, Sawaguchi T.

Eur J Pharmacol. 2006 Feb 17;532(1-2):81-7. Epub 2006 Feb 7.

PMID:
16464448

Supplemental Content

Support Center